AbbVie, Chiesi Farmaceutici, Novartis, Pharmaxis, AstraZeneca and more

Global Cystic Fibrosis Treatment Market

DUBLIN, May 24, 2023 (Globe Newswire) — The Global Cystic Fibrosis Treatment Market Report and Forecast 2023-2031 report has been added. of ResearchAndMarkets.com Recruitment.

The global market value in 2022 was USD 8.3 billion due to the spread of the disease and the introduction of new treatments worldwide.

The global cystic fibrosis treatment market size is expected to grow at a CAGR of 13.4% during the forecast period 2023-2031, reaching a value of USD 25.7 billion by 2031.

Cystic Fibrosis Market: Introduction

Cystic fibrosis (CF) is a genetic disease that primarily affects the lungs and digestive system. Thick mucus builds up in the airways and other organs, causing frequent infections, lung damage, and difficulty breathing. CF is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which regulates salt and water transport in and out of cells. There is currently no cure for CF, and treatment aims to manage symptoms and prevent complications.

CF is a rare disease, affecting approximately 70,000 people worldwide. It is most commonly diagnosed in infancy or early childhood, but it can also be diagnosed in adulthood. The incidence of CF varies by population, but is higher in people of European descent. Treatment options for CF include airway clearance techniques, antibiotics to treat infections, and drug therapies that target specific symptoms of the disease. In severe cases, a lung transplant may be required. Research is ongoing to develop new treatments and improve the quality of life of CF patients.

Key trends in the cystic fibrosis market
Key trends in the Cystic Fibrosis market include:

• Emerging new treatments: Ongoing research and development in this area is developing new and more effective treatments for cystic fibrosis. These treatments are aimed at addressing the underlying cause of the disease rather than just treating the symptoms.

• Growing Focus on Personalized Medicine: As our understanding of the genetics of cystic fibrosis increases, there is a growing focus on personalized medicine. This involves tailoring treatment regimens to each individual patient’s specific genetic mutations to achieve the best possible outcome.

• Rising Prevalence of Cystic Fibrosis: Cystic fibrosis is a relatively rare disease, but its prevalence is increasing worldwide. This is partly due to better diagnostics and screening, allowing more people to be identified and treated.

• Increased Awareness and Advocacy: Increased awareness of cystic fibrosis among the public has led to increased funding for research and development and improved patient access to care.

• Advances in gene therapy: Gene therapy has shown promise as a potential treatment for cystic fibrosis, and ongoing research in this area will lead to new, more effective treatments in the coming years. expected to be produced.

story continues

Cystic Fibrosis Market Segmentation
Market breakdown by treatment method

Market breakdown by drug class

Market breakdown by drug molecule type

Market breakdown by route of administration

Market Breakdown by Treatment Channel

Market breakdown by distribution channel

• hospital pharmacy

• retail pharmacy

• online pharmacy

• others

Cystic Fibrosis Market by Region

North America

• united states of america

• Canada

Europe

• England

• Germany

• France

• Italy

• others

Asia Pacific

• China

• Japan

• India

• ASEAN

• Australia

• others

latin america

• Brazil

• Argentina

• Mexico

• others

Middle East and Africa

• Saudi Arabia

• United Arab Emirates

• Nigeria

• South Africa

• others

Cystic Fibrosis Market Scenario

Cystic fibrosis is a genetic disease that affects the respiratory, digestive, and reproductive systems. It is caused by mutations in her CFTR gene, which causes her body to produce thick mucus. This mucus can cause blockages in the lungs, pancreas, and other organs, leading to serious health problems such as lung infections, malnutrition, and infertility.

The cystic fibrosis treatment market is growing rapidly due to the increasing prevalence of this disease and the introduction of new treatments. Several new drugs have been approved for the treatment of cystic fibrosis in recent years, some of which target underlying genetic defects and have been shown to improve lung function and reduce the frequency of exacerbations. Contains a CFTR modulator that

The market is also witnessing a shift towards personalized medicine with the development of therapies that target specific mutations in the CFTR gene. This approach has the potential to improve treatment outcomes and reduce healthcare costs by ensuring patients receive the most effective treatment for their specific genetic mutation.

Overall, the cystic fibrosis market is expected to continue growing in the coming years owing to continued research and development efforts, growing awareness of the disease, and growing demand for personalized treatment options.

Cystic Fibrosis Market: Competitor Landscape

Key features of the market report include patent analysis, grant analysis, clinical trial analysis, funding and investment analysis, partnerships, and collaboration analysis by key players. Key players in the Cystic Fibrosis market are:

• AbbVie Inc.

• Allergan

• Chiesi Farmaceutici SpA

• F. Hoffman-La Roche K.K.

• Gilead Sciences

• Novartis AG

• Pharmaxis Co., Ltd.

• PTC Therapeutics

• Vertex Pharmaceuticals

• Demegen Co., Ltd.

• Mole research application

• Araxia

• Alclesta Therapeutics, Inc.

• AstraZeneca

• Genentech Inc.

• Pfizer Japan Inc

• Mylan, Nevada

• Alclesta Therapeutics, Inc.

• Teva Pharmaceutical Industries, Inc.

• Bayer AG

Key Attributes:

Main topics covered:

1.First of all

2 Overview

3 Overview of Cystic Fibrosis Disease

4 Patient profile

5 Epidemiological Analysis of Cystic Fibrosis

6 Global Cystic Fibrosis Market Overview

7 Global Cystic Fibrosis Market Outlook

8 challenges and unmet needs in cystic fibrosis

9 Medical expenses

10 Global Cystic Fibrosis Market Dynamics

11 Global Cystic Fibrosis Market Segmentation

12 North America Cystic Fibrosis Market

13 European Cystic Fibrosis Market

14 Asia-Pacific Cystic Fibrosis Market

15 Latin America Cystic Fibrosis Market

16 Middle East and Africa Cystic Fibrosis Market

17 Regulatory framework

18 Patent Analysis

19 Grant analysis

20 Clinical trial analysis

21 Funding and investment analysis

22 Analysis of partnerships and collaborations

23 Supplier Situation

24 Cystic Fibrosis Market – Distribution Models (Additional Insights)

25 Key Opinion Leaders (KOL) Insights (Additional Insights)

26 Company Competitiveness Analysis (Additional Insights)

27 Payment Methods (Additional Insights)

For more information on this report, please visit https://www.researchandmarkets.com/r/4vtxq4.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900